Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Cell Reports
|
February 4, 2026
Delactylation of the tumor suppressor ARHGDIB drives metastasis and chemoresistance in bladder cancer
Guanghui Xu, Yuqin Li, Shan Peng, et al.
Optics Express
|
August 9, 2017
Picosecond mid-infrared optical parametric amplifier based on LiInSe<sub>2</sub> with tenability extending from 3.6 to 4.8 μm
Shi-Bo Dai, Ning Jia, Jia-Kang Chen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study
Hong Yan, April W Mao, Dan Li, et al.
Eclinicalmedicine
|
June 8, 2026
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China
Chao Zhang, Ben-Yuan Jiang, Li-Xu Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression
Chuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Molecular Cancer Therapeutics
|
June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu, Shan Peng, Patrick G Pilié, et al.
Cancer Letters
|
March 26, 2026
AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors
Hong Yan, April W Mao, Dan Li, et al.
Nature Communications
|
February 6, 2026
Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND
Dongyin He, Haoran Hu, Kai Xiao, et al.
BMC Genomics
|
October 14, 2024
Microsatellite density landscapes illustrate short tandem repeats aggregation in the complete reference human genome
Yun Xia, Douyue Li, Tingyi Chen, et al.
Cell Reports. Medicine
|
June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Cell Reports
|
February 4, 2026
Delactylation of the tumor suppressor ARHGDIB drives metastasis and chemoresistance in bladder cancer
Guanghui Xu, Yuqin Li, Shan Peng, et al.
Optics Express
|
August 9, 2017
Picosecond mid-infrared optical parametric amplifier based on LiInSe<sub>2</sub> with tenability extending from 3.6 to 4.8 μm
Shi-Bo Dai, Ning Jia, Jia-Kang Chen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 28, 2024
AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and prognosis: an international multicenter retrospective study
Hong Yan, April W Mao, Dan Li, et al.
Eclinicalmedicine
|
June 8, 2026
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant non-small cell lung cancer (NEOTIDE/CTONG2104): phase II trial and correlative genomic analysis in China
Chao Zhang, Ben-Yuan Jiang, Li-Xu Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression
Chuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.
Molecular Cancer Therapeutics
|
June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu, Shan Peng, Patrick G Pilié, et al.
Cancer Letters
|
March 26, 2026
AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors
Hong Yan, April W Mao, Dan Li, et al.
Nature Communications
|
February 6, 2026
Analysis of the transcriptomic and metabolomic landscape of prostate cancer with different anatomical origins using snFLARE-seq and mxFRIZNGRND
Dongyin He, Haoran Hu, Kai Xiao, et al.
BMC Genomics
|
October 14, 2024
Microsatellite density landscapes illustrate short tandem repeats aggregation in the complete reference human genome
Yun Xia, Douyue Li, Tingyi Chen, et al.
Cell Reports. Medicine
|
June 19, 2024
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
Chao Zhang, Yu-Xuan Sun, Ding-Cheng Yi, et al.
Page
of 18